Shares of Protagonist Therapeutics (PTGX) surged in the last session on above-average trading volume. Recent upward revisions to earnings estimates could translate into further near-term price appreciation, making the stock a short-term bullish momentum candidate.
Shares of Protagonist Therapeutics (PTGX) surged in the last session on above-average trading volume. Recent upward revisions to earnings estimates could translate into further near-term price appreciation, making the stock a short-term bullish momentum candidate.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
